Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy. [electronic resource]
Producer: 20190329Description: 1695 p. digitalISSN:- 1440-1746
- Aged
- Antineoplastic Agents, Immunological -- adverse effects
- Bile Ducts, Intrahepatic -- diagnostic imaging
- Carcinoma, Non-Small-Cell Lung -- therapy
- Cholangiopancreatography, Magnetic Resonance
- Cholangitis -- chemically induced
- Humans
- Immunotherapy -- adverse effects
- Lung Neoplasms -- therapy
- Male
- Nivolumab -- adverse effects
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.